Clinical and Laboratory Characteristics of Patients Positive for aPL and of SLE Patients Negative for aPL
. | aPL-Negative Patients (n = 18) . | aPL-Positive Patients (n = 18) . | P Value . |
---|---|---|---|
Age (yrs) | |||
Mean ± SD | 37 ± 8 | 38 ± 11 | NS |
Range | 23-50 | 17-53 | |
Male sex (n) (%) | 1 (6) | 2 (11) | NS |
Diabetes mellitus (n) (%) | 3 (17) | 4 (22) | NS |
Hypertension (n) (%) | 4 (22) | 5 (28) | NS |
Smoking (n) (%) | 5 (28) | 4 (22) | NS |
F1 + 2 (nmol/L) | |||
Mean | 1.02 | 1.83 | .0001 |
SD | 0.38 | 0.56 | |
IPF2α-III (pg/mg creatinine) | |||
Median | 135 | 242 | .0001 |
Range | 80-210 | 72-405 | |
IPF2α-VI (pg/mg creatinine) | |||
Median | 1,057 | 1,600 | .006 |
Range | 449-1,780 | 580-2,400 |
. | aPL-Negative Patients (n = 18) . | aPL-Positive Patients (n = 18) . | P Value . |
---|---|---|---|
Age (yrs) | |||
Mean ± SD | 37 ± 8 | 38 ± 11 | NS |
Range | 23-50 | 17-53 | |
Male sex (n) (%) | 1 (6) | 2 (11) | NS |
Diabetes mellitus (n) (%) | 3 (17) | 4 (22) | NS |
Hypertension (n) (%) | 4 (22) | 5 (28) | NS |
Smoking (n) (%) | 5 (28) | 4 (22) | NS |
F1 + 2 (nmol/L) | |||
Mean | 1.02 | 1.83 | .0001 |
SD | 0.38 | 0.56 | |
IPF2α-III (pg/mg creatinine) | |||
Median | 135 | 242 | .0001 |
Range | 80-210 | 72-405 | |
IPF2α-VI (pg/mg creatinine) | |||
Median | 1,057 | 1,600 | .006 |
Range | 449-1,780 | 580-2,400 |
Statistical analysis was performed by Mann-Whitney-U test.
Abbreviation: NS, not significant.